Navigation Links
Almac Launch Biomarkers for Biopharma

CRAIGAVON, Northern Ireland, August 2, 2010 /PRNewswire/ -- Almac today announced the launch of Biomarkers for biopharma (; a range of solutions specifically designed to meet the needs of the biopharma industry.

Almac's solutions are to support biopharma companies in adopting biomarker strategies to enable them to better understand their drug, improve their drug's success rate, improve the drug's value and ultimately maximise their drug's potential.

The use of biomarkers can add substantial value to a compound in development and the ability to identify those patients most likely to respond to a therapy greatly increases the chances of success and the licensing potential of the drug.

Biomarkers for biopharma solutions include pharmacodynamic solutions, patient selection markers, assay development and bioinformatics / biostatistics consultancy.

President and Managing Director of Almac's Diagnostics ( division, Professor Paul Harkin said:

"With Biomarkers for biopharma, we have combined a range of key solutions which are ideally suited to growing biopharma companies. For these companies, it is of critical importance that they maximise the potential success of the drugs in their pipeline and the incorporation of a biomarker strategy enables them to do this."

Almac support and guide companies, enabling biomarker strategies that will maximise their drugs and business's potential.

For further information on Biomarkers for biopharma visit

Notes to Editors

About Almac

The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and technology (IVRS & Web), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors. The company employs over 2,600 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Construction of the company's new $120m North American Headquarters started in July 2008 and will be completed 2010.

Almac's Diagnostics division is a personalised medicine company focused on the discovery and development of biomarkers. They utilise their proprietary technology and extensive experience and expertise to offer solutions to biotech and Pharma partners. Almac focus on providing a range of services including exploratory biomarker discovery studies, verification studies for existing markers, assay development and biomarker validation.

For more information about the Almac Group, please visit or e-mail

    Michael Sloan
    Almac Diagnostics
    Tel: +44-28-38337575

    Tristan Jervis
    De Facto Communications
    Tel: +44-2078-613019

SOURCE Almac Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MultiCell Technologies Launches New Web Site
2. Launch of BioOptimal™ MF-SL Microfilters for Bioprocessing
3. Winner Medical Launches Its First Online PurCotton(R) Store in China on
4. Boston Scientific Launches Neuroform EZ(TM) Stent System in U.S. and Europe
5. Bioniche Pharma and Synerx Launch Isosulfan Blue Injection 1%
6. Sysmex America to Launch Complete Cell Image Analysis Portfolio at AACC
7. MAQUET Cardiovascular Launches Advanced VASOVIEW Technology for Endoscopic Vessel Harvesting Procedures in Cardiac Surgery
8. Education Tactics for Thought Leaders, Physicians, Patients and Payers to Support Successful Oncology Product Launches
9. Mylan Launches the Generic Version of Solodyn®, 45 mg, 90 mg and 135 mg Tablets, Announces Settlement Agreement with Medicis
10. Latina Actress and Author Dayanara Torres Launches Online Asthma Education Resource for Hispanic Community in Partnership with Merck and AAFA
11. Dynatronics Launches E-Commerce Website
Post Your Comments:
(Date:11/26/2015)... -- 3D bioprinting market is expected to ... report by Grand View Research Inc. Rising prevalence of chronic ... transplantation is expected to boost the market growth, as 3D ... --> 3D bioprinting market is expected to ... report by Grand View Research Inc. Rising prevalence of chronic ...
(Date:11/26/2015)... 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in the ... Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new 247-page ... therapeutic drug monitoring market, including emerging tests, technologies, ...
(Date:11/26/2015)... 26, 2015 ... "2016 Future Horizons and Growth Strategies ... Market: Supplier Shares, Country Segment Forecasts, Competitive ... offering. --> ) has ... Future Horizons and Growth Strategies in the ...
Breaking Medicine Technology:
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... offering factory direct sauna parts and accessories. , Sauna accessories help improve ... the bather’s style and personality. From basic styles for the purist looking for ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 10, 2015, ... District Court of Connecticut on behalf of a home health care worker who provided ... or former home health care workers employed by Humana, Inc., Humana at Home, Inc., ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... across the country to celebrate their sobriety and show through pictures what a ... and after” photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health ... launches new Wimbledon Athletics Facebook page to educate the public, parents ... cardiac abnormalities. About 2,000 people under the age of 25 die from sudden ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens is ... and moderate facial wrinkling. While many patients are aware of the benefits of Botox® ... Botox® delivers to those suffering with discomfort, soreness, and pain as a result of ...
Breaking Medicine News(10 mins):